Dendritic cell responses to self-assembled monolayers of defined chemistries

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 4, 2010, Pages 1487-1499

  Shankar, Sucharita P ^a   Petrie, Timothy A ^b   García, Andrés J ^b   Babensee, Julia E ^a  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Adjuvant; Apoptosis; Dendritic cells; Self assembled monolayers

Indexed keywords

ALKANETHIOLS; ANTI-INFLAMMATORIES; ANTIGEN RECEPTORS; APOPTOSIS; APOPTOTIC; APOPTOTIC MARKERS; BIOMATERIAL SURFACES; COATED SURFACE; CYTOTOXIC T LYMPHOCYTES; DENDRITIC CELLS; ELEVATED LEVEL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE EFFECTS; INTERLEUKIN-6; PROINFLAMMATORY; SAMS; T CELLS; TUMOR NECROSIS FACTORS;

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; BIOMATERIALS; CELL DEATH; DENDRIMERS; GENE EXPRESSION; SURFACE CHEMISTRY;

SELF ASSEMBLED MONOLAYERS;

ALKANETHIOL DERIVATIVE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GOLD; INTERLEUKIN 6; NANOCOATING; SELF ASSEMBLED MONOLAYER; THIOL DERIVATIVE; TITANIUM; TOLL LIKE RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL INTERACTION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NICK END LABELING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHENOTYPE; PHYSICAL CHEMISTRY; PROTEIN PROCESSING; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ALKANES; ANTIGENS, CD; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL SHAPE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GOLD; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MATERIALS TESTING; SULFHYDRYL COMPOUNDS; SURFACE PROPERTIES; T-LYMPHOCYTES; TISSUE ENGINEERING; TITANIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77349127138     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32487     Document Type: Article

References (87)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
2. Atala A. Tissue engineering and regenerative medicine: Concepts for clinical application. Rejuvenation Res 2004;7:15-31.
3. Kulig KM, Vacanti JP. Hepatic tissue engineering. Transpl Immunol 2004;12:303-310.
4. Lavik E, Langer R. Tissue engineering: Current state and perspectives. Appl Microbiol Biotechnol 2004;65:1-8.
5. Anderson JM. Inflammatory response to implants. Trans Am Soc Artif Intern Organs 1988;34:101-107.
6. Llull R. Immune considerations in tissue engineering. Clin Plast Surg 1999;26:549-568.
7. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005;23:47-55.
8. Badylak SF, Valentin JE, Ravindra A, McCabe G, Stewart-Akers AM. Macrophage phenotype as a determinant of orthobiologic scaffold remodeling. Tissue Eng Part A 2008;14:1835-1842.
9. Linnes MP, Ratner BD, Giachelli CM. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 2007;28:5298-5306.
10. Babensee JE, Anderson JM, McIntire LV, Mikos AG. Host response to tissue engineered devices. Adv Drug Deliv Rev 1998;33:111-139.
11. Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999;17:1075-1081.
12. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
13. Kurts C. Constitutive class-I restricted exogenous presentation of self-antigens in vivo. J Exp Med 1996;184:923-930.
14. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
15. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001;413:36-37.
16. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
17. Janeway CAJ, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
18. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-787.
19. Janeway CAJ, Medzhitov R. Introduction: The role of innate immunity in the adaptive immune response. Semin Immunol 1998;10:349-350.
20. Zhang G, Ghosh S. Toll-like receptor-mediated NF-κB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107:13-19.
21. Babensee JE, Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 2005;74:503-510.
22. Ertl HC, Varga I, Xiang ZQ, Kaiser K, Stephens L, Otvos LJ. Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines. Vaccine 1996;14:879-885.
23. Walker KB, Xing DKL, Sesardic D, Corbel MJ. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres. Dev Biol Stand 1998;92:259-267.
24. Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. J Microencapsul 2001;18:723-732.
25. Matzelle MM, Babensee JE. Humoral and T cell immune responses to model antigen delivered with biomaterials used in tissue engineering. Biomaterials 2004;25:295-304.
26. Bennewitz NL, Babensee JE. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 2005;26:2991-2999.
27. Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004;71:45-54.
28. Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A 2006;79:393-408.
29. Mrksich M, Chen CS, Xia Y, Dike LE, Ingber DE, Whitesides GM. Controlling cell attachment on contoured surfaces with self-assembled monolayers of alkanethiolates on gold. Proc Natl Acad Sci USA 1996;93:10775-10778.
30. Sigal GB, Mrksich M, Whitesides GM. Effect of surface wettability on the adsorption of proteins and detergents. J Am Chem Soc 1998;120:3464-3473.
31. Luk Y, Kato M, Mrksich M. Self-assembled monolayers of alkanethiolates presenting mannitol groups are inert to protein adsorption and cell attachment. Langmuir 2000;16:9604-9608.
32. Harder P, Grunze M, Dahint R, Whitesides GM, Laibinis PE. Molecular conformation on oligo (ethylene glycol)-terminated self-assembled monolayers on gold and silver surfaces determines their ability to resist protein adsorption. J Phys Chem B 1998;102:426-436.
33. McClary KB, Ugarova T, Grainger DW. Modulating fibroblast adhesion, spreading and proliferation using self-assembled monolayer films of alkylthiolates on gold. J Biomed Mater Res 2000;50:428-439.
34. Schwendel D, Hayashi T, Dahint R, Pertsin A, Grunze M, Steitz R, Schreiber F. Interaction of water with self-assembled monolayers: Neutron reflectivity measurements of the water density in the interface region. Langmuir 2003;19:2284-2293.
35. Lindbald M, Lestelius M, Johansson A, Tengvall P, Thomsen P. Cell and soft tissue interactions with methyl- and hydroxyl-terminated alkane thiols on gold surfaces. Biomaterials 1997;18:1059-1068.
36. Silver JH, Hergenrother RW, Lin JC, Lim F, Lin HB, Okada T, Chaudhury MK, Cooper SL. Surface and blood-contacting properties of alkylsiloxane monolayers supported on silicone rubber. J Biomed Mater Res 1995;29:535-548.
37. Tegoulia VA, Cooper SL. Leukocyte adhesion on model surfaces under flow: Effects of surface chemistry, protein adsorption, and shear rate. J Biomed Mater Res 2000;50:291-301.
38. Kalltorp M, Oblogina S, Jacobsson S, Karlsson A, Tengvall P, Thomsen P. In vivo cell recruitment, cytokine release and chemiluminescence response at gold, and thiol functionalized surfaces. Biomaterials 1999;20:2123-37.
39. Shen M, Horbett TA. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 2001;57:336-345.
40. Dadsetan M, Jones JA, Hiltner A, Anderson JM. Surface chemistry mediates adhesive structure, cytoskeletal organization, and fusion of macrophages. J Biomed Mater Res A 2004;71:439-448.
41. Sperling C, Schweiss RB, Streller U, Werner C. In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials 2005;26:6547-6557.
42. Barbosa JN, Barbosa MA, Aguas AP. Inflammatory responses and cell adhesion to self-assembled monolayers of alkanethiolates on gold. Biomaterials 2004;25:2557-2563.
43. Barbosa JN, Barbosa MA, Aguas AP. Inflammatory cell recruitment and adhesion to methyl-terminated self-assembled monolayers: Effect of implantation time. Microsc Res Tech 2005;66:37-42.
44. Barbosa JN, Madureira P, Barbosa MA, Aguas AP. The influence of functional groups of self-assembled monolayers on fibrous capsule formation and cell recruitment. J Biomed Mater Res A 2006;76:737-743.
45. Keselowsky BG, Collard DM, Garcia AJ. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res A 2003;66:247-259.
46. Michael KE, Vernekar VN, Keselowsky BG, Meredith JC, Latour RA, Garcia AJ. Adsorption-induced conformational changes in fibronectin due to interactions with well-defined surface chemistries. Langmuir 2003;19:8033-8040.
47. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002;2:77-84.
48. Geitjenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000;100:575-585.
49. van Kooyk Y, Geitjenbeek TBH. DC-SIGN: Escape mechanism for pathogens. Nat Rev Immunol 2003;3:697-709.
50. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eible B, Niederwieser D, Schuler G. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-151.
51. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
52. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
53. Leverkus M, McLellan AD, Heldmann M, Eggert AO, Brocker EB, Koch N, Kampgen E. MHC class II-mediated apoptosis in dendritic cells: A role for membrane-associated and mitochondrial signaling pathways. Int Immunol 2003;15:993-1006.
54. Zang W, Kalache S, Lin M, Schroppel B, Murphy BC. MHC class II-mediated apoptosis by a nonpolymorphic MHC Class II peptide proceeds by activation of protein kinase. J Am Soc Nephrol 2005;16:3661-3668.
55. Zang W, Murphy B. Peptide-mediated immunosuppression. Am J Ther 2005;12:592-599.
56. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006;311:1160-1164.
57. Skoberne M, Beignon AS, Larsson M, Bhardwaj N. Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol 2005;289:259-292.
58. Wallet MA, Sen P, Tisch R. Immunoregulation of dendritic cells. Clin Med Res 2005;3:166-175.
59. Newton PJ, Weller IV, Katz DR, Chain BM. Autologous apoptotic T cells interact with dendritic cells but do not affect their surface phenotype or their ability to induce recall immune responses Clin Exp Immunol 2003;133:50-58.
60. Ferguson TA, Herndon J, Elzey B, Griffith TS, Scheoenberger S, Green DR. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness. J Immunol 2002;168:5589-5595.
61. Clayton AR, Prue RL, Harper L, Drayson MT, Savage COS. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: Relevance to systemic vasculitis. Arthritis Rheum 2003;48:2362-2374.
62. Duffield JS. The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond) 2003;104:27-38.
63. Brodbeck WG, Shive MS, Colton E, Nicholas ZP, Anderson JM. Interleukin-4 inhibits tumor necrosis factor-α induced and spontaneous apoptosis of biomaterial-adherent macrophages. J Lab Clin Med 2002;139:90-100.
64. Walunus TL, Bluestone JA. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J Immunol 1998;160:3855-3860.
65. Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. CTLA-4 and T cell activation. Curr Opin Immunol 1999;11:294-300.
66. Orabona C, Puccetti P, Vacca C, Bicciato S, Luchini A, Fallarino F, Bianchi R, Velardi E, Perruccio K, Velardi A, Bronte V, Fioretti MC, Grohmann U. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 2006;107:2846-2857.
67. Bertho N, Laupeze B, Mooney N, LeBerre C, Charron D, Drenou B, Fauchet R. HLA-DR mediated cell death is associated with, but not induced by TNF-alpha secretion in APC. Hum Immunol 2001;62:106-112.
68. Davis DM. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol 2007;7:238-243.
69. Bayry J, Lacroix-Desmazes S, Donkova-Petrini V, Carbonneil C, Misra N, Lepelletier Y, Delignat S, Varambally S, Oksenhendler E, Le Y, Debre' M, Kazatchkine MD, Hermine O, Kaveri SV. Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci USA 2004;101:14210-14215.
70. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 2005;175:15-20.
71. Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, Brown EJ, Maliszewski C, Lindberg FP, Oldenborg A, Ullrich A, Delespesse G, Sarfati M. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α: Down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 2001;167:2547-2554.
72. Johansson U, Londei M. Ligation of CD47 during monocytes differentiation into dendritic cells results in reduced capacity for interleukin-12 production. Scand J Immunol 2004;59:50-57.
73. Nasr BA, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): Uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J Leukoc Biol 2006;80:774-786.
74. Skoberne M, Somersan S, Almodovar W, Truong T, Petrova K, Henson PM, Bhardwaj N. The apoptotic cell receptor CR3 but not {alpha}v{beta}5 is a regulator of human dendritic cell immunostimulatory function. Blood 2006;108:947-955.
75. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151-155.
76. Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O'Neil CP, Lee LK, Swartz MA, Hubbell JA. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 2007;25:1159-1164.
77. Bivas-Benita M, van Meijgaarden KE, Franken KL, Junginger HE, Borchard G, Ottenhoff TH, Geluk A. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201- restricted T-cell. Vaccine 2004;22:1609-1615.
78. Porporatto C, Bianco ID, Correa SG. Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration. J Leukoc Biol 2005;78:62-69.
79. Wang Y, Gao S, Ye WH, Yoon HS, Yang YY. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006;5:791-796.
80. MacEwan MR, Brodbeck WG, Matsuda T, Anderson JM. Monocyte/lymphocyte interactions and the foreign body response: In vitro effects of biomaterial surface chemistry. J Biomed Mater Res A 2005;74:285-293.
81. Chang DT, Colton E, Anderson JM. Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation. J Biomed Mater Res A 2009;89:490-498.
82. Barbosa JN, Barbosa MA, Aguas AP. Adhesion of human leukocytes to biomaterials: An in vitro study using alkanethiolate monolayers with different chemically functionalized surfaces. J Biomed Mater Res A 2003;65:429-434.
83. Barbosa JN, Madureira P, Barbosa MA, Aguas AP. The attraction of Mac-1+ phagocytes during acute inflammation by methyl-coated self-assembled monolayers. Biomaterials 2005;26:3021-3027.
84. Whitlock BB, Gardai S, Fadok V, Bratton D, Henson PM. Differential roles for alpha(M)beta(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms. J Cell Biol 2000;151:1305-1320.
85. Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, Ben-Tal O, Kutikov I, Gill O, Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 2002;196:1553-1561.
86. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: A homeostatic mechanism in inflammation. Immunity 1996;5:653-666.
87. Shankar SP, Chen II, Keselowsky BG, García AJ, Babensee JE. Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries. J Biomed Mater Res A 2010;92:1329-1342.